Takeda Pharmaceutical (TAK) Projected to Post Quarterly Earnings on Thursday

Takeda Pharmaceutical (NYSE:TAKGet Free Report) is projected to announce its earnings results before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of $0.34 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Takeda Pharmaceutical Trading Down 0.2 %

Shares of Takeda Pharmaceutical stock opened at $13.35 on Thursday. The business has a fifty day simple moving average of $13.30 and a two-hundred day simple moving average of $13.89. Takeda Pharmaceutical has a 1 year low of $12.57 and a 1 year high of $15.08. The company has a market capitalization of $42.46 billion, a price-to-earnings ratio of 23.01, a P/E/G ratio of 0.24 and a beta of 0.51. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.28 and a quick ratio of 0.77.

About Takeda Pharmaceutical

(Get Free Report)

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.

Featured Stories

Earnings History for Takeda Pharmaceutical (NYSE:TAK)

Receive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.